(ASTE) Astec Industries - Overview
Stock: Asphalt Plants, Crushers, Pavers, Screeners, Conveyors
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.26% |
| Yield on Cost 5y | 0.84% |
| Yield CAGR 5y | 3.68% |
| Payout Consistency | 92.4% |
| Payout Ratio | 25.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 39.9% |
| Relative Tail Risk | -14.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.48 |
| Alpha | 56.55 |
| Character TTM | |
|---|---|
| Beta | 1.051 |
| Beta Downside | 0.825 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.04% |
| CAGR/Max DD | 0.24 |
Description: ASTE Astec Industries January 20, 2026
Astec Industries (NASDAQ: ASTE) designs, engineers, manufactures, markets, and services equipment and components used primarily in road building and related construction activities worldwide. The firm operates two distinct segments: Infrastructure Solutions, which supplies a broad portfolio of asphalt-plant equipment, concrete-handling systems, heating and dust-control technologies, and related services; and Materials Solutions, which produces crushing and screening equipment, mobile and modular processing plants, and associated automation and consulting services for a diverse customer base that includes contractors, quarry operators, utilities, and government agencies.
Key quantitative indicators (as of FY 2024) show revenue of roughly $1.2 billion, with the Infrastructure Solutions segment contributing about 55 % of sales and delivering an operating margin near 8 %. The business is highly sensitive to U.S. and global infrastructure spending cycles-particularly federal highway-rebuilding programs and stimulus-driven construction demand-which historically drive a 1.5-2× lift in order backlogs during multi-year funding periods. Additionally, Astec’s exposure to commodity-price volatility (e.g., asphalt binder and aggregate costs) can compress margins, while its growing telematics and automation offerings present a secular upside as contractors seek productivity gains.
For a deeper quantitative assessment, the ValueRay platform offers a granular view of ASTE’s valuation metrics.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 47.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 2.62 > 1.0 |
| NWC/Revenue: 36.47% < 20% (prev 34.36%; Δ 2.11% < -1%) |
| CFO/TA 0.05 > 3% & CFO 61.9m > Net Income 47.9m |
| Net Debt (282.7m) to EBITDA (130.5m): 2.17 < 3 |
| Current Ratio: 2.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (22.9m) vs 12m ago 0.32% < -2% |
| Gross Margin: 27.20% > 18% (prev 0.24%; Δ 2695 % > 0.5%) |
| Asset Turnover: 113.3% > 50% (prev 120.3%; Δ -6.95% > 0%) |
| Interest Coverage Ratio: 7.23 > 6 (EBITDA TTM 130.5m / Interest Expense TTM 13.7m) |
Altman Z'' 5.14
| A: 0.37 (Total Current Assets 817.5m - Total Current Liabilities 318.3m) / Total Assets 1.35b |
| B: 0.41 (Retained Earnings 559.4m / Total Assets 1.35b) |
| C: 0.08 (EBIT TTM 99.1m / Avg Total Assets 1.21b) |
| D: 0.77 (Book Value of Equity 521.6m / Total Liabilities 680.0m) |
| Altman-Z'' Score: 5.14 = AAA |
Beneish M -2.54
| DSRI: 1.03 (Receivables 193.1m/175.2m, Revenue 1.37b/1.28b) |
| GMI: 0.90 (GM 27.20% / 24.48%) |
| AQI: 1.86 (AQ_t 0.25 / AQ_t-1 0.13) |
| SGI: 1.07 (Revenue 1.37b / 1.28b) |
| TATA: -0.01 (NI 47.9m - CFO 61.9m) / TA 1.35b) |
| Beneish M-Score: -2.54 (Cap -4..+1) = A |
What is the price of ASTE shares?
Over the past week, the price has changed by +17.88%, over one month by +20.75%, over three months by +26.28% and over the past year by +72.28%.
Is ASTE a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ASTE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 56.5 | -1.6% |
| Analysts Target Price | 56.5 | -1.6% |
| ValueRay Target Price | 68.1 | 18.6% |
ASTE Fundamental Data Overview February 03, 2026
P/E Forward = 15.1286
P/S = 0.8142
P/B = 1.6559
P/EG = 2.6
Revenue TTM = 1.37b USD
EBIT TTM = 99.1m USD
EBITDA TTM = 130.5m USD
Long Term Debt = 323.6m USD (from longTermDebt, last quarter)
Short Term Debt = 28.4m USD (from shortTermDebt, last quarter)
Debt = 352.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 282.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.39b USD (1.11b + Debt 352.0m - CCE 71.8m)
Interest Coverage Ratio = 7.23 (Ebit TTM 99.1m / Interest Expense TTM 13.7m)
EV/FCF = 30.72x (Enterprise Value 1.39b / FCF TTM 45.4m)
FCF Yield = 3.26% (FCF TTM 45.4m / Enterprise Value 1.39b)
FCF Margin = 3.32% (FCF TTM 45.4m / Revenue TTM 1.37b)
Net Margin = 3.50% (Net Income TTM 47.9m / Revenue TTM 1.37b)
Gross Margin = 27.20% ((Revenue TTM 1.37b - Cost of Revenue TTM 996.5m) / Revenue TTM)
Gross Margin QoQ = 25.28% (prev 26.73%)
Tobins Q-Ratio = 1.03 (Enterprise Value 1.39b / Total Assets 1.35b)
Interest Expense / Debt = 2.07% (Interest Expense 7.30m / Debt 352.0m)
Taxrate = 21.0% (US default 21%)
NOPAT = 78.3m (EBIT 99.1m * (1 - 21.00%))
Current Ratio = 2.57 (Total Current Assets 817.5m / Total Current Liabilities 318.3m)
Debt / Equity = 0.53 (Debt 352.0m / totalStockholderEquity, last quarter 668.9m)
Debt / EBITDA = 2.17 (Net Debt 282.7m / EBITDA 130.5m)
Debt / FCF = 6.23 (Net Debt 282.7m / FCF TTM 45.4m)
Total Stockholder Equity = 658.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.97% (Net Income 47.9m / Total Assets 1.35b)
RoE = 7.27% (Net Income TTM 47.9m / Total Stockholder Equity 658.7m)
RoCE = 10.09% (EBIT 99.1m / Capital Employed (Equity 658.7m + L.T.Debt 323.6m))
RoIC = 9.46% (NOPAT 78.3m / Invested Capital 827.4m)
WACC = 7.83% (E(1.11b)/V(1.47b) * Re(9.79%) + D(352.0m)/V(1.47b) * Rd(2.07%) * (1-Tc(0.21)))
Discount Rate = 9.79% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.20%
[DCF Debug] Terminal Value 70.99% ; FCFF base≈30.4m ; Y1≈20.0m ; Y5≈9.12m
Fair Price DCF = N/A (negative equity: EV 183.7m - Net Debt 282.7m = -99.0m; debt exceeds intrinsic value)
EPS Correlation: 14.16 | EPS CAGR: -43.65% | SUE: -2.64 | # QB: 0
Revenue Correlation: 47.07 | Revenue CAGR: 7.54% | SUE: 1.11 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.73 | Chg30d=-0.065 | Revisions Net=+1 | Analysts=2
EPS next Year (2026-12-31): EPS=3.25 | Chg30d=+0.055 | Revisions Net=+1 | Growth EPS=+5.9% | Growth Revenue=+6.3%